These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11790386)

  • 1. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients.
    Spreux-Varoquaux O; Bensimon G; Lacomblez L; Salachas F; Pradat PF; Le Forestier N; Marouan A; Dib M; Meininger V
    J Neurol Sci; 2002 Jan; 193(2):73-8. PubMed ID: 11790386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
    J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
    Anneser JM; Chahli C; Borasio GD
    Neuroscience; 2006 Sep; 141(4):1879-86. PubMed ID: 16820266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Sen I; Nalini A; Joshi NB; Joshi PG
    J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS).
    Niebroj-Dobosz I; Janik P
    Acta Neurol Scand; 1999 Jul; 100(1):6-11. PubMed ID: 10416506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
    Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE
    Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular changes in motor neuron cell culture produced by cytotoxic cerebrospinal fluid from patients with amyotrophic lateral sclerosis.
    Gomez-Pinedo U; Yáñez M; Matías-Guiu J; Galán L; Guerrero-Sola A; Benito-Martin MS; Vela A; Arranz-Tagarro JA; García AG
    Neurologia; 2014; 29(6):346-52. PubMed ID: 24144827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.
    Steinacker P; Verde F; Fang L; Feneberg E; Oeckl P; Roeber S; Anderl-Straub S; Danek A; Diehl-Schmid J; Fassbender K; Fliessbach K; Foerstl H; Giese A; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer GB; Lauer M; Pinkhardt EH; Prudlo J; Rosenbohm A; Schneider A; Schroeter ML; Tumani H; von Arnim CAF; Weishaupt J; Weydt P; Ludolph AC; Yilmazer Hanke D; Otto M;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):239-247. PubMed ID: 29142138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament phosphorylation is enhanced in cultured chick spinal cord neurons exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Nagaraja TN; Gourie-Devi M; Nalini A; Raju TR
    Acta Neuropathol; 1994; 88(4):349-52. PubMed ID: 7839827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients.
    Bräuer S; Günther R; Sterneckert J; Glaß H; Hermann A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).
    Niebroj-Dobosz I; Dziewulska D; Janik P
    Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological changes in the rat brain and spinal cord following prolonged intracerebroventricular infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients are similar to those caused by the disease.
    Gómez-Pinedo U; Galán L; Yañez M; Matias-Guiu J; Valencia C; Guerrero-Sola A; Lopez-Sosa F; Brin JR; Benito-Martin MS; Leon-Espinosa G; Vela-Souto A; Lendinez C; Guillamon-Vivancos T; Matias-Guiu JA; Arranz-Tagarro JA; Barcia JA; Garcia AG
    Neurologia (Engl Ed); 2018 May; 33(4):211-223. PubMed ID: 27570180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.
    Fujita K; Honda M; Hayashi R; Ogawa K; Ando M; Yamauchi M; Nagata Y
    J Neurol Sci; 1998 Jun; 158(1):53-7. PubMed ID: 9667778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?
    Chełstowska B; Kuźma-Kozakiewicz M
    Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?
    Mendonça DM; Martins SC; Higashi R; Muscara MN; Neto VM; Chimelli L; Martinez AM
    Amyotroph Lateral Scler; 2011 Mar; 12(2):144-7. PubMed ID: 21198418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL; Krieger C; Hansen S; Eisen A
    Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.